Launer B.M., McVary K.T., Ricke W.A., Lloyd G.L. The rising worldwide impact of benign prostatic hyperplasia // BJU Int. 2021. Vol. 127, No. 6. P. 722–728. DOI: 10.1111/bju.15286.
DOI: 10.1111/bju.15286

Devlin C.M., Simms M.S., Maitland N.J. Benign prostatic hyperplasia — what do we know? // BJU Int. 2021. Vol. 127, No. 4. P. 389–399. DOI: 10.1111/bju.15229.
DOI: 10.1111/bju.15229

Miernik A., Gratzke C. Current treatment for benign prostatic hyperplasia // Dtsch Arztebl Int. 2020. Vol. 117, No. 49. P. 843–854. DOI: 10.3238/arztebl.2020.0843.
DOI: 10.3238/arztebl.2020.0843

Dornbier R., Pahouja G., Branch J., McVary K.T. The New American Urological Association Benign Prostatic Hyperplasia Clinical Guidelines: 2019 Update // CurrUrol Rep. 2020. Vol. 21, No. 9. P. 32. DOI: 10.1007/s11934-020-00985-0.
DOI: 10.1007/s11934-020-00985-0

Murad L., Bouhadana D., Nguyen D.D., et al. Treating LUTS in men with benign prostatic obstruction: a review article // Drugs Aging. 2023. Vol. 40, No. 9. P. 815–836. DOI: 10.1007/s40266-023-01054-0.
DOI: 10.1007/s40266-023-01054-0

Vuichoud C., Loughlin K.R. Benign prostatic hyperplasia: epidemiology, economics and evaluation // Can J Urol. 2015. Vol. 22 Suppl 11–6

Lerner L.B., McVary K.T., Barry M.J., et al. Management of lower urinary tract symptoms attributed to benign prostatic hyperplasia: AUA GUIDELINE PART II — surgical evaluation and treatment // J Urol. 2021. Vol. 206, No. 4. P. 818–826. DOI: 10.1097/JU.0000000000002184.
DOI: 10.1097/JU.0000000000002184

Азимов О.Х., Хашимов У.Т., Боймурадов Н.У. Критические состояния у больных после аденомэктомии // Вестник экстренной медицины. 2013. № 3. C. 46.

Ottaiano N., Shelton T., Sanekommu G., Benson C.R. Surgical complications in the management of benign prostatic hyperplasia treatment // CurrUrol Rep. 2022. Vol. 23, No. 5. P. 83–92. DOI: 10.1007/s11934-022-01091-z.
DOI: 10.1007/s11934-022-01091-z

Geremew L.M., Gelaw S.A., Beyene A.D. Assessing the complications of Monopolar Transurethral Resection of the Prostate (M-TURP) using Clavien–Dindo complications grading system // Ethiop J Health Sci. 2022. Vol. 32, No. 3. P. 605–612. DOI: 10.4314/ejhs.v32i3.17.
DOI: 10.4314/ejhs.v32i3.17

Bearelly P., Avellino G.J. The role of benign prostatic hyperplasia treatments in ejaculatory dysfunction // Fertil Steril. 2021. Vol. 116, No. 3. P. 611–617. DOI: 10.1016/j.fertnstert.2021.07.1199.
DOI: 10.1016/j.fertnstert.2021.07.1199

Manfredi C., García-Gómez B., Arcaniolo D., et al. Impact of Surgery for benign prostatic hyperplasia on sexual function: a systematic review and meta-analysis of erectile function and ejaculatory function // Eur Urol Focus. 2022. Vol. 8, No. 6. P. 1711–1732. DOI: 10.1016/j.euf.2022.06.007.
DOI: 10.1016/j.euf.2022.06.007

М.Н. Рустамов, О.Ф. Галиуллин, А.З. Винаров. Эякуляторные нарушения после оперативного лечения гиперплазии простаты // Урология. 2023. № 1. C. 46–52. DOI: 10.18565/urology.2023.1.46-52.
DOI: 10.18565/urology.2023.1.46-52

Camara-Lopes G., Mattedi R., Antunes A.A., et al. The histology of prostate tissue following prostatic artery embolization for the treatment of benign prostatic hyperplasia // Int Braz J Urol. 2013. Vol. 39, No. 2. P. 222–227. DOI: 10.1590/S1677-5538.IBJU.2013.02.11.
DOI: 10.1590/S1677-5538.IBJU.2013.02.11

Карпов В.К., Капранов С.А., Шапаров Б.М., и др. Суперселективная эмболизация артерий предстательной железы в лечении ДГПЖ // Урология. 2019. № 3. C. 134–141. DOI: 10.18565/urology.2019.3.134-141.
DOI: 10.18565/urology.2019.3.134-141

Abt D., Müllhaupt G., Hechelhammer L., et al. Prostatic artery embolisation versus transurethral resection of the prostate for benign prostatic hyperplasia: 2-yr outcomes of a randomised, open-label, single-centre trial // Eur Urol. 2021. Vol. 80, No. 1. P. 34–42. DOI: 10.1016/j.eururo.2021.02.008.
DOI: 10.1016/j.eururo.2021.02.008

Dias U.S., de Moura M.R.L., Viana P.C.C., et al. Prostatic artery embolization: indications, preparation, techniques, imaging evaluation, reporting, and complications // Radiographics. 2021. Vol. 41, No. 5. P. 1509–1530. DOI: 10.1148/rg.2021200144.
DOI: 10.1148/rg.2021200144

Knight G.M., Talwar A., Salem R., Mouli S. Systematic review and meta-analysis comparing prostatic artery embolization to gold-standard transurethral resection of the prostate for benign prostatic hyperplasia // Cardiovasc Intervent Radiol. 2021. Vol. 44, No. 2. P. 183–193. DOI: 10.1007/s00270-020-02657-5.
DOI: 10.1007/s00270-020-02657-5

Яковец Е.А., Неймарк А.И., Карпенко А.А., Яковец Я.В. Эмболизация артерий предстательной железы в лечении больных аденомой предстательной железы с высоким хирургическим риском // Андрология и генитальная хирургия. 2010. № 1. С. 38–43.

Carnevale F.C., Antunes A.A., Baroni R.H., et al. Prostatic artery embolization as a primary treatment for benign prostatic hyperplasia: preliminary results in two patients // Cardiovasc Intervent Radiol. 2010. Vol. 33, No. 2. P. 355–361. DOI: 10.1007/s00270-009-9727-z.
DOI: 10.1007/s00270-009-9727-z

Pisco J.M., Pinheiro L.C., Bilhim T., et al. Prostatic arterial embolization to treat benign prostatic hyperplasia // J VascInterv Radiol. 2011. Vol. 22, No. 1. P. 11–19. DOI: 10.1016/j.jvir.2010.09.030.
DOI: 10.1016/j.jvir.2010.09.030

Pisco J., Campos Pinheiro L., Bilhim T., et al. Prostatic arterial embolization for benign prostatic hyperplasia: short- and intermediate-term results // Radiology. 2013. Vol. 266, No. 2. P. 668–677.

Garcia-Monaco R., Garategui L., Kizilevsky N., et al. Human cadaveric specimen study of the prostatic arterial anatomy: implications for arterial embolization // J VascInterv Radiol. 2014. Vol. 25, No. 2. P. 315–322. DOI: 10.1016/j.jvir.2013.10.026.
DOI: 10.1016/j.jvir.2013.10.026

Zhang G., Wang M., Duan F., et al. Radiological findings of prostatic arterial anatomy for prostatic arterial embolization: preliminary study in 55 chinese patients with benign prostatic hyperplasia // PLoS One. 2015. Vol. 10, No. 7. P. e0132678. DOI: 10.1371/journal.pone.0132678.
DOI: 10.1371/journal.pone.0132678

Bilhim T., Pisco J.M., Furtado A., et al. Prostatic arterial supply: demonstration by multirow detector angio CT and catheter angiography // Eur Radiol. 2011. Vol. 21, No. 5. P. 1119–1126. DOI: 10.1007/s00330-010-2015-0.
DOI: 10.1007/s00330-010-2015-0

Amouyal G., Chague P., Pellerin O., et al. Safety and efficacy of occlusion of large extra-prostatic anastomoses during prostatic artery embolization for symptomatic BPH // Cardiovasc Intervent Radiol. 2016. Vol. 39, No. 9. P. 1245–1255. DOI: 10.1007/s00270-016-1412-4.
DOI: 10.1007/s00270-016-1412-4

Wang M.Q., Guo L.P., Zhang G.D., et al. Prostatic arterial embolization for the treatment of lower urinary tract symptoms due to large (>80 mL) benign prostatic hyperplasia: results of midterm follow-up from Chinese population // BMC Urol. 2015. Vol. 16. P. 33. DOI: 10.1186/s12894-015-0026-5.
DOI: 10.1186/s12894-015-0026-5

Amouyal G., Pellerin O., Del Giudice C., et al. Bilateral arterial embolization of the prostate through a single prostatic artery: a case series // Cardiovasc Intervent Radiol. 2017. Vol. 40, No. 5. P. 780–787. DOI: 10.1007/s00270-016-1540-x.
DOI: 10.1007/s00270-016-1540-x

Bilhim T., Pisco J.M., Rio Tinto H., et al. Prostatic arterial supply: anatomic and imaging findings relevant for selective arterial embolization // J Vasc Interv Radiol. 2012. Vol. 23, No. 11. P. 1403–1415. DOI: 10.1016/j.jvir.2012.07.028.
DOI: 10.1016/j.jvir.2012.07.028

Wang M.Q., Duan F., Yuan K., et al. Benign prostatic hyperplasia: cone-beam CT in conjunction with DSA for identifying prostatic arterial anatomy // Radiology. 2017. Vol. 282, No. 1. P. 271–280. DOI: 10.1148/radiol.2016152415.
DOI: 10.1148/radiol.2016152415

Хайрутдинов Е.Р., Воронцов И.М., Жариков С.Б., и др. Преимущества трансрадиального сосудистого доступа при эмболизации простатических артерий // Российский онкологический журнал. 2017. Т. 22, № 2. С. 84–88. DOI: 10.18821/1028-9984-2017-22-2-84-88.
DOI: 10.18821/1028-9984-2017-22-2-84-88

Teichgräber U., Aschenbach R., Diamantis I., et al. Prostate Artery Embolization: Indication, Technique and Clinical Results // Rofo. 2018. Vol. 190, No. 9. P. 847–855. DOI: 10.1055/a-0612-8067.
DOI: 10.1055/a-0612-8067

Mirakhur A., McWilliams J.P. Prostate Artery Embolization for Benign Prostatic Hyperplasia: Current Status // Can Assoc Radiol J. 2017. Vol. 68, No. 1. P. 84–89. DOI: 10.1016/j.carj.2016.06.003.
DOI: 10.1016/j.carj.2016.06.003

Powell T., Kellner D., Ayyagari R. Benign prostatic hyperplasia: clinical manifestations, imaging, and patient selection for prostate artery embolization // Tech VascInterv Radiol. 2020. Vol. 23, No. 3. P. 100688. DOI: 10.1016/j.tvir.2020.100688.
DOI: 10.1016/j.tvir.2020.100688

Christidis D., Clarebrough E., Ly V., et al. Prostatic artery embolization for benign prostatic obstruction: assessment of safety and efficacy // World J Urol. 2018. Vol. 36, No. 4. P. 575–584. DOI: 10.1007/s00345-018-2220-z.
DOI: 10.1007/s00345-018-2220-z

Неймарк Б.А., Торбик Д.В. Отдаленные результаты лечения доброкачественной гиперплазии предстательной железы методом суперселективной эмболизации артерий простаты // Современные проблемы науки и образования. 2016. № 6. C. 24.

Salvador Hidalgo D., Bernardello Ureta M., Sbriglio M., et al. Prostatic artery embolization treatment for patients with benign prostatic hyperplasia who are permanent urinary catheter users ineligible for de-obstructive surgery // Actas Urol Esp (Engl Ed). 2021. Vol. 45, No. 7. P. 481–485. DOI: 10.1016/j.acuroe.2021.06.008.
DOI: 10.1016/j.acuroe.2021.06.008

Jeong C.W., Park Y.H., Ku J.H., et al. Minimally invasive management of postoperative bleeding aerradical prostatectomy: transarterial embolization // J Endourol. 2010. Vol. 24, No. 9. P. 1529–1533. DOI: 10.1089/end.2009.0686.
DOI: 10.1089/end.2009.0686

Tapping C.R., Crew J., Proteroe A., Boardman P. Prostatic artery embolization (PAE) for prostatic origin bleeding in the context of prostate malignancy // Acta Radiol Open. 2019. Vol. 8, No. 6. P. 2058460119846061. DOI: 10.1177/2058460119846061.
DOI: 10.1177/2058460119846061

Pereira K., Halpern J.A., McClure T.D., et al. Role of prostate artery embolization in the management of refractory haematuria of prostatic origin // BJU Int. 2016. Vol. 118, No. 3. P. 359–365. DOI: 10.1111/bju.13524.
DOI: 10.1111/bju.13524

Stezewska A., Stezewska M., Zabicki B., Salagierski M. The application of prostate artery embolization in the management of intractable prostate bleeding // Cent European J Urol. 2020. Vol. 73, No. 3. P. 328–335. DOI: 10.5173/ceju.2020.0149.
DOI: 10.5173/ceju.2020.0149

Chen J.W., Shin J.H., Tsao T.F., et al. Prostatic arterial embolization for control of hematuria in patients with advanced prostate cancer // J Vasc Interv Radiol. 2017. Vol. 28, No. 2. P. 295–301. DOI: 10.1016/j.jvir.2016.10.010.
DOI: 10.1016/j.jvir.2016.10.010

Frandon J., Bey E., Hamard A., et al. Early results of unilateral prostatic artery embolization as a focal therapy in patients with prostate cancer under active surveillance: cancer prostate embolisation, a pilot study // J Vasc Interv Radiol. 2021. Vol. 32, No. 2. P. 247–255. DOI: 10.1016/j.jvir.2020.10.002.
DOI: 10.1016/j.jvir.2020.10.002

Mordasini L., Hechelhammer L., Diener P.A., et al. D. Prostatic artery embolization in the treatment of localized prostate cancer: a bicentric prospective proof-of-concept study of 12 patients // J Vasc Interv Radiol. 2018. Vol. 29, No. 5. P. 589–597. DOI: 10.1016/j.jvir.2018.01.766.
DOI: 10.1016/j.jvir.2018.01.766

Неймарк А.И., Тачалов М.А., Неймарк Б.А., и др. Использование суперселективной рентгенэндоваскулярной химиоэмболизации в лечении пациентов с локализованным раком предстательной железы: наш первый опыт // Онкоурология. 2015. № 1. С. 42–46.

Pisco J., Bilhim T., Costa N.V., Ribeiro M.P., et al. Safety and efficacy of prostatic artery chemoembolization for prostate cancer — initial experience // J Vasc Interv Radiol. 2018. Vol. 29, No. 3. P. 298–305. DOI: 10.1016/j.jvir.2017.10.013.
DOI: 10.1016/j.jvir.2017.10.013

Peacock J., Sikaria D., Maun-Garcia L., et al. A Proof-of-concept study on the use of prostate artery embolization before definitive radiation therapy in prostate cancer // Adv Radiat Oncol. 2020. Vol. 6, No. 3. P. 100619. DOI: 10.1016/j.adro.2020.11.004.
DOI: 10.1016/j.adro.2020.11.004

Haddad H., Hermani H., Bischoff P., et al. Permanent interstitial brachytherapy for prostate cancer implementing neoadjuvant prostatic artery embolization // Brachytherapy. 2022. Vol. 21, No. 3. P. 308–316. DOI: 10.1016/j.brachy.2021.12.004.
DOI: 10.1016/j.brachy.2021.12.004

Carnevale F.C., Antunes A.A. Prostatic artery embolization for enlarged prostates due to benign prostatic hyperplasia. How I do it // Cardiovasc Intervent Radiol. 2013. Vol. 36, No. 6. P. 1452–1463. DOI: 10.1007/s00270-013-0680-5.
DOI: 10.1007/s00270-013-0680-5

Bagla S., Martin C.P., van Breda A., et al. Early results from a United States trial of prostatic artery embolization in the treatment of benign prostatic hyperplasia // J Vasc Interv Radiol. 2014. Vol. 25, No. 1. P. 47–52. DOI: 10.1016/j.jvir.2013.09.010.
DOI: 10.1016/j.jvir.2013.09.010

Malling B., Røder M.A., Lindh M., et al. Palliative prostate artery embolization for prostate cancer: a case series // Cardiovasc Intervent Radiol. 2019. Vol. 42, No. 10. P. 1405–1412. DOI: 10.1007/s00270-019-02227-4.
DOI: 10.1007/s00270-019-02227-4

Parikh N., Keshishian E., Manley B., et al. Effectiveness and safety of prostatic artery embolization for the treatment of lower urinary tract symptoms from benign prostatic hyperplasia in men with concurrent localized prostate cancer // J Vasc Interv Radiol. 2021. Vol. 32, No. 7. P. 1053–1061. DOI: 10.1016/j.jvir.2021.03.534.
DOI: 10.1016/j.jvir.2021.03.534